Award Sub-Category: Minimally Invasive and Implantable Devices

iDose TR is a first-of-its-kind anchored ocular micro-implant that
revolutionizes glaucoma management. iDose TR delivers continuous
long-term prostaglandin analog therapy directly into the eye for IOP
control with proven safety and patient tolerability.

Abbott’s TriClip™ transcatheter edge-to-edge repair (TEER) system is a
first-of-its-kind, minimally invasive device purposefully designed for
the heart’s hard-to-treat tricuspid valve, offering a safe, effective
and non-surgical solution for patients suffering from severe tricuspid
regurgitation (TR).

Abbott’s Esprit™ BTK Everolimus Eluting Resorbable Scaffold System
(Esprit™ BTK System) is a groundbreaking and first-of-its-kind
dissolving stent that sets a new standard of care for individuals with
Peripheral Artery Disease (PAD), a condition that affects over 200
million people globally.